Advisors Asset Management Inc. Sells 2,132 Shares of Axon Enterprise, Inc $AXON

Advisors Asset Management Inc. lowered its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 10.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 17,588 shares of the biotechnology company’s stock after selling 2,132 shares during the period. Advisors Asset Management Inc.’s holdings in Axon Enterprise were worth $12,622,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Brighton Jones LLC purchased a new stake in shares of Axon Enterprise during the fourth quarter worth $480,000. NewEdge Advisors LLC lifted its holdings in Axon Enterprise by 41.1% during the 1st quarter. NewEdge Advisors LLC now owns 2,294 shares of the biotechnology company’s stock worth $1,207,000 after purchasing an additional 668 shares in the last quarter. Empowered Funds LLC boosted its stake in Axon Enterprise by 8.4% in the 1st quarter. Empowered Funds LLC now owns 2,028 shares of the biotechnology company’s stock worth $1,067,000 after purchasing an additional 157 shares during the period. Woodline Partners LP grew its holdings in Axon Enterprise by 40.6% during the 1st quarter. Woodline Partners LP now owns 6,932 shares of the biotechnology company’s stock valued at $3,646,000 after buying an additional 2,003 shares in the last quarter. Finally, Sivia Capital Partners LLC bought a new stake in shares of Axon Enterprise during the second quarter valued at about $284,000. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON opened at $446.97 on Wednesday. The stock’s 50-day moving average is $564.47 and its 200 day moving average is $653.88. The stock has a market cap of $35.27 billion, a price-to-earnings ratio of 141.45, a P/E/G ratio of 13.07 and a beta of 1.48. Axon Enterprise, Inc has a 1-year low of $396.41 and a 1-year high of $885.91. The company has a current ratio of 3.12, a quick ratio of 2.89 and a debt-to-equity ratio of 0.57.

Insider Buying and Selling

In related news, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction on Wednesday, January 7th. The shares were sold at an average price of $619.01, for a total transaction of $6,190,100.00. Following the transaction, the chief executive officer owned 3,100,997 shares of the company’s stock, valued at approximately $1,919,548,152.97. This trade represents a 0.32% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Brittany Bagley sold 2,000 shares of the business’s stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $580.00, for a total transaction of $1,160,000.00. Following the completion of the sale, the chief financial officer directly owned 103,501 shares of the company’s stock, valued at $60,030,580. This represents a 1.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 48,040 shares of company stock worth $27,249,338 in the last ninety days. 5.70% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of equities analysts have recently commented on AXON shares. Morgan Stanley cut their price objective on shares of Axon Enterprise from $760.00 to $713.00 and set an “overweight” rating for the company in a research report on Wednesday, December 17th. Piper Sandler cut their price target on shares of Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating for the company in a report on Wednesday, November 5th. William Blair reaffirmed an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 3rd. Barclays lowered their price objective on Axon Enterprise from $861.00 to $702.00 and set an “overweight” rating on the stock in a research report on Thursday, November 6th. Finally, UBS Group reduced their target price on Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating for the company in a research report on Wednesday, November 5th. Fifteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $805.71.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.